Drug Trial Radar · NCT05745883
Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
Last checked: Nov 19, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55
Actual
Start
Apr 4, 2023
Primary completion
Oct 9, 2025
Study completion Jan 16, 2026
Sponsor
- Lead sponsor
- Disc Medicine, IncIndustry
- Sponsor type
- Industry
- First posted
- Feb 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 1b study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney Disease and Anemia.
Conditions
- Chronic Kidney Diseases
- Anemia of Chronic Kidney Disease
Interventions
DISC-0974Drug
DISC-0974 is administered subcutaneously
PlaceboDrug
Placebo is administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse eventsTime frame: up to 145 days
- Incidence of clinically abnormal vital signsTime frame: up to 145 days
- Incidence of abnormal laboratory test resultsTime frame: up to 145 days
- Incidence of clinically abnormal physical examTime frame: up to 145 days
- Incidence of clinically abnormal electrocardiogramsTime frame: up to 145 days
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
UCLA Clinical and Translational Research
Los Angeles, California
US Renal Care Inc.
Lone Tree, Colorado
Accel Research
DeLand, Florida
Total Research Group
Miami, Florida
Flourish Research
Winter Park, Florida
Nephrology and Hypertension Specialists, PC-Dalton
Dalton, Georgia
CARE Institute - Boise Kidney
Boise, Idaho
Center for Advanced Kidney Research PLC
Saint Clair Shores, Michigan
Mayo Clinic
Rochester, Minnesota
Centricity Research
Columbus, Ohio
Clinical Advancement Center, PLLC
San Antonio, Texas
Endeavor Clinical Trials
San Antonio, Texas
Washington Nephrology Associates, LLP
Alexandria, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.